Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MammoScreen BD

K-Number: K241561 · 2024-10-02

ApplicantTherapixel
Decision Date2024-10-02
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

MammoScreen BD is a medical device manufactured by Therapixel. It received FDA 510(k) clearance on 2024-10-02 under approval number K241561. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MammoScreen BD?

MammoScreen BD is a medical device that received FDA 510(k) clearance on 2024-10-02. It is manufactured by Therapixel. The 510(k) number is K241561.

When was MammoScreen BD approved by the FDA?

MammoScreen BD received FDA 510(k) clearance on 2024-10-02, under approval number K241561.

What company makes MammoScreen BD?

MammoScreen BD is manufactured by Therapixel.

What is the FDA product code for MammoScreen BD?

The FDA product code for MammoScreen BD is QIH.

Other Devices by Therapixel

Related Devices (Code: QIH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.